Curis Lifesciences IPO 2025| Curis Lifesciences Limited IPO| Curis Lifesciences share price| Curis SME IPO| NSE SME IPO 2025| Pharma IPO India| Curis IPO allotment| Curis Lifesciences listing date| Curis IPO GMP today
Date: November 2025
Category: IPO / Pharmaceuticals / SME Market
Tags: Curis Lifesciences IPO, Pharma SME IPO 2025, Curis Lifesciences NSE EMERGE, Curis Lifesciences share price, SME IPO India, Curis IPO review, Curis Lifesciences listing gain, Pharma IPO India
🧬 Company Overview
Curis Lifesciences Limited is a Gujarat-based pharmaceutical manufacturing company engaged in the production of a wide range of formulations — tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments.
Founded in 2016, the company operates both under its own brand and on a contract manufacturing (loan licence) basis for other pharmaceutical marketers. Its manufacturing facility is located in a well-established industrial zone near Ahmedabad, Gujarat — a major pharma hub of India.
With a focus on quality, compliance, and diversified formulations, Curis Lifesciences aims to strengthen its domestic and export presence through this public issue.
💰 IPO Details at a Glance
| Particular | Details |
|---|---|
| IPO Type | Fresh Issue |
| Issue Size | ₹27.52 crore (approx.) |
| Face Value | ₹10 per equity share |
| Price Band | ₹120 – ₹128 per share |
| Minimum Lot Size | 2,000 shares (₹2.56 lakh at upper band) |
| Issue Opens | November 7, 2025 |
| Issue Closes | November 11, 2025 |
| Allotment Date (Tentative) | November 12, 2025 |
| Listing Date (Tentative) | November 14, 2025 |
| Listing Platform | NSE EMERGE (SME Segment) |
| Lead Manager | Beeline Capital Advisors Pvt Ltd |
| Registrar | Bigshare Services Pvt Ltd |
📊 Financial Performance Snapshot
Curis Lifesciences has displayed consistent growth and profitability in recent years.
| Financial Year | Total Revenue (₹ Cr) | PAT (₹ Cr) |
|---|---|---|
| FY2023 | 36.42 | 1.88 |
| FY2024 | 35.87 | 4.87 |
| FY2025 | 49.65 | 6.11 |
| Q1 FY2026 (Jul 2025) | 19.51 | 2.87 |
Key highlight:
Profitability has more than tripled from FY23 to FY25, showcasing improving margins and operational efficiency.
🎯 Objects of the Issue
The IPO proceeds will be used for:
- 🔹 Upgrading existing manufacturing facilities (₹2.44 crore)
- 🔹 Construction of a new storage facility (₹3.62 crore)
- 🔹 Prepayment/repayment of secured loans (₹1.86 crore)
- 🔹 Registration of products in new international markets (₹2.69 crore)
- 🔹 Working capital requirements (₹11.25 crore)
- 🔹 General corporate purposes
This combination indicates the company’s intention to expand capacity, strengthen finances, and push international reach.
👨⚕️ Promoters & Shareholding
| Category | Pre-Issue | Post-Issue |
|---|---|---|
| Promoters | 92.68% | 68.03% |
| Public | 7.32% | 31.97% |
Promoters:
The company is promoted by professionals with extensive experience in pharmaceutical manufacturing and distribution. The high pre-issue holding shows strong promoter commitment.
🌟 Strengths
- ✅ Strong presence in formulation manufacturing across multiple dosage forms.
- ✅ Steady financial growth and increasing profit margins.
- ✅ Expansion into international registrations expected to boost exports.
- ✅ Low debt post-issue, with part of IPO proceeds allocated to repayment.
- ✅ Manufacturing base in Gujarat, one of India’s top pharma clusters.
- ✅ Long-term relationships with multiple pharma marketers ensure repeat business.
⚠️ Risks & Concerns
- ❌ SME platform listing — limited liquidity, smaller investor base.
- ❌ High minimum investment (₹2.56 lakh) may restrict retail participation.
- ❌ Dependence on contract manufacturing may lead to client concentration risk.
- ❌ Pharma sector subject to regulatory compliance and product approval delays.
- ❌ Competition from larger and well-funded pharma manufacturers.
📈 Valuation View
At an upper band of ₹128 and PAT of ₹6.11 crore (FY25), post-issue valuation gives an indicative P/E range around 20x–22x, which seems reasonable for a growth-stage pharma SME with export ambitions.
While listing gains may depend on investor sentiment, the fundamentals and clear use of funds make this IPO moderately attractive for medium-term investors.
One More SME IPO: Shining Tools Ltd. IPO – Full Details, Valuation & Market Outlook
🧭 Investor Outlook
Curis Lifesciences Ltd. offers exposure to India’s fast-growing pharmaceutical manufacturing space with improving fundamentals, expanding infrastructure, and moderate valuations.
However, investors must remember that SME IPOs carry higher volatility and lower trading volumes post-listing.
👉 Short-term traders should be cautious and may wait for listing performance.
👉 Long-term investors with risk appetite may consider subscribing for steady growth exposure to the SME pharma segment.
💬 Market Buzz & Expectations
The pharma SME space has been actively watched by retail and HNI investors. Given Curis Lifesciences’ healthy profitability trend and Gujarat manufacturing base, moderate oversubscription is expected in retail and NII categories.
If listing sentiment remains strong, listing premium of 8–12% could be seen, though investors are advised to track GMP trends closer to listing day.
🧠 Expert View
Analysts tracking SME IPOs believe the company’s efficient cost structure, export potential, and clear capital utilization plan support a healthy business outlook.
However, they highlight that the ₹2.56 lakh minimum retail investment makes this issue more suitable for HNIs or experienced SME investors.
💡 Final Verdict
| Parameter | Verdict |
|---|---|
| Business Model | 👍 Scalable & Diversified |
| Financials | 📈 Improving YoY |
| Valuation | ⚖️ Reasonable |
| Risk | ⚠️ Moderate (SME-specific) |
| Listing Outlook | 💹 Positive to Moderate |
| Ideal For | Medium-term Investors with Risk Appetite |
Verdict: ⭐ “Subscribe with Caution for Medium-Term” ⭐
Curis Lifesciences IPO 2025| Curis Lifesciences Limited IPO| Curis Lifesciences share price| Curis SME IPO| NSE SME IPO 2025| Pharma IPO India| Curis IPO allotment| Curis Lifesciences listing date| Curis IPO GMP today
Subscription:
| Day | Anchor | QIB | NII | BNII(>10l) | SNII(<10L) | Retail | Total |
|---|---|---|---|---|---|---|---|
| Day-1 | 1 | 8.34 | 1.19 | 1.53 | 0.50 | 0.87 | 3.07 |
| Day-2 | 1 | 8.34 | 4.06 | 4.60 | 2.95 | 3.80 | 5.15 |
| Day-3 | 1 | 96.17 | 115.46 | 142.74 | 60.38 | 44.28 | 74.39 |
GMP Trend:
| Date | GMP |
|---|---|
| 07 Nov 2025 | ₹7.50(5.86%) |
| 10 Nov 2025 | ₹8.00(6.25%) |
| 11 Nov 2025 | ₹9.00(7.03%) |
It should be noted that IPO GMP is subject to extreme volatility, so an investment decision based solely on Patel Retail IPO GMP will prove risky. Therefore, before to investing, consider all factors and make the right investment decision whether to invest in Patel Retail IPO or not.
📢 Join Our Market Community
📱 Stay updated on IPOs, Results & Market News:
- WhatsApp Channel: Join Now
- Telegram: Follow Updates
- Arattai: Connect with Us
How to Check IPO Allotment Status:
Maashitla Securities
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
NSE Website
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
BSE Webiste
To check IPO allotment status, follow the steps below:
- Click on the below allotment status check button.
- Select Company Name.
- Enter your PAN Number, Application Number or DP Client ID (Anyone).
- Click on Search.
📌 Stock Market Disclaimer
- Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
- The information provided on this platform is for educational and informational purposes only. It should not be considered as investment advice, stock recommendations, or financial guidance.
- ⚠️ Stock Market Investments
- Investing in equities, derivatives, mutual funds, and other financial instruments involves market risks, volatility, and the possibility of capital loss.
- Past performance of stocks or indices is not indicative of future returns.
- Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
- ⚠️ IPO (Initial Public Offerings)
- IPO details, issue size, subscription data, and allotment status shared here are based on publicly available information from company filings, stock exchanges, and merchant bankers.
- Investing in IPOs carries risks including listing volatility, business uncertainties, and sector performance dependency.
- Neither acceptance of applications nor allotment guarantees profits. Investors should evaluate their risk appetite before subscribing.
- ⚠️ GMP (Grey Market Premium)
- Grey Market Premium (GMP) is an unofficial and unregulated indicator of expected IPO listing price.
- GMP data is collected from market observers and informal trading circles; it does not have any legal or SEBI recognition.
- GMP values are highly speculative and may differ significantly from actual listing prices. Investors should not rely solely on GMP while taking investment decisions.
- ✅ General Advisory
- We do not provide any buy/sell/hold recommendations.
- Readers and investors are solely responsible for their investment actions and decisions.
- This platform, its authors, and affiliates are not liable for any direct or indirect financial loss arising from the use of this information.
- 🔒 Always invest responsibly and diversify your portfolio.
Open Demat Account
by Mirae Asset (m,Stock)
-
Indian Stock Market Today: Full Analysis + Tomorrow Outlook
Nifty Market Analysis Today| Bank Nifty Prediction| Fin Nifty Levels| Midcap Market Outlook| Indian Stock Market Today 📌 Index Performance…
-
Cloudflare Global Outage: What Happened and How It Impacted the World & India
Cloudflare Outage 2025| Cloudflare Outage| Cloudflare Down| Website Outage| CDN Issue| India Internet Issue| Global Internet Outage| DNS Failure| Tech…
